Chapter 4 —— 90 —— 11. Gonçalves, M.A.; Vries,A.A.. Adenovirus: from foe to friend. Rev. Med. Virol. 2006, 16, 167–186. 12. Gonçalves, M.A.. Adeno-associated virus: from defective virus to effective vector. Virol. J. 2005, 2, 43. 13. Holkers, M.; Maggio, I.; Henriques, S.F.; Janssen, J.M.; Cathomen, T.; Gonçalves, M.A.. Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat. Methods 2014, 11, 1051–1057. 14. Medert, R.; Thumberger, T.; Tavhelidse-Suck, T.; Hub, T.; Kellner, T.; Oguchi, Y.; Dlugosz, S.; Zimmermann, F.; Wittbrodt, J.; Freichel,M. Efficient single copy integration via homology-directed repair (scHDR) by 5′ modification of large DNA donor fragments in mice. Nucleic Acids Res. 2023, 51, e14. 15. Dever, D.P.; Bak, R.O.; Reinisch, A.; Camarena, J.; Washington, G.; Nicolas, C.E.; Pavel-Dinu, M.; Saxena, N.; Wilkens, A.B.; Mantri, S.; et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature 2016, 539, 384–389. 16. Holkers, M.; de Vries, A.A.; Gonçalves, M.A. Nonspaced inverted DNA repeats are preferential targets for homology-directed gene repair in mammalian cells. Nucleic Acids Res. 2012, 40, 1984–1999. 17. Gaj, T.; Staahl, B.T.; Rodrigues, G.M.C.; Limsirichai, P.; Ekman, F.K.; Doudna, J.A.; Schaffer, D.V. Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery. Nucleic Acids Res. 2017, 45, e98. 18. Tasca, F.; Wang, Q.; Goncalves, M.. Adenoviral vectors meet gene editing: a rising partnership for the genomic engineering of human stem cells and their progeny. Cells 2020, 9, 953. 19. Ricobaraza, A.; Gonzalez-Aparicio, M.; Mora-Jimenez, L.; Lumbreras, S.; HernandezAlcoceba, R.. High-capacity adenoviral vectors: expanding the scope of gene therapy. Int. J. Mol. Sci. 2020, 21, 3643. 20. Brescia, M.; et al. High-capacity adenoviral vectors permit robust and versatile testing of DMD gene repair tools and strategies in Human cells. Cells 2020, 9, 869. 21. Gray, J.T.; Zolotukhin, S.. Design and construction of functional AAV vectors. Methods Mol. Biol. 2011, 807, 25–46. 22. Levesque, S.; Mayorga, D.; Fiset, J.P.; Goupil, C.; Duringer, A.; Loiselle, A.; Bouchard, E.; Agudelo, D.; Doyon, Y.. Marker-free co-selection for successive rounds of prime editing in human cells. Nat. Commun. 2022, 13, 5909. 23. Grimm, D.; Kay, M.A.; Kleinschmidt, J.A.. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol. Ther. 2003, 7, 839–850.
RkJQdWJsaXNoZXIy MTk4NDMw